REPORT ID 3196

China Contract Pharmaceutical Manufacturing Market Research Report 2017

Publish Date
12-Dec-17
Pages
108
Format
Electronic (PDF)

The global Contract Pharmaceutical Manufacturing market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Contract Pharmaceutical Manufacturing development status and future trend in China, focuses on top players in China, also splits Contract Pharmaceutical Manufacturing by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    Catalent
    DPx
    Lonza
    Piramal Healthcare
    Aenova
    Jubilant
    Famar
    Boehringer Ingelheim
    Fareva Holding
    AbbVie
    Nipro Corp
    Vetter
    Sopharma
    DPT Laboratories
    Recipharm
    NextPharma
    Dishman
    Aesica

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
    Active Pharmaceutical Ingredients (API)
    Finished Dosage Formulations (FDF)

On the basis of the end users/application, this report covers
    Big Pharma
    Specialty/Midsize
    Generics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Contract Pharmaceutical Manufacturing Market Research Report 2017
1 Contract Pharmaceutical Manufacturing Overview
    1.1 Product Overview and Scope of Contract Pharmaceutical Manufacturing
    1.2 Classification of Contract Pharmaceutical Manufacturing by Product Category
        1.2.1 China Contract Pharmaceutical Manufacturing Sales (K Pcs) Comparison by Type (2012-2022)
        1.2.2 China Contract Pharmaceutical Manufacturing Sales (K Pcs) Market Share by Type in 2016
        1.2.3 Active Pharmaceutical Ingredients (API)
        1.2.4 Finished Dosage Formulations (FDF)
    1.3 China Contract Pharmaceutical Manufacturing Market by Application/End Users
        1.3.1 China Contract Pharmaceutical Manufacturing Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Big Pharma
        1.3.3 Specialty/Midsize
        1.3.4 Generics
        1.3.5 Other
    1.4 China Contract Pharmaceutical Manufacturing Market by Region
        1.4.1 China Contract Pharmaceutical Manufacturing Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022)
        1.4.3 East China Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022)
        1.4.4 Southwest China Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022)
        1.4.5 Northeast China Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022)
        1.4.6 North China Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022)
        1.4.7 Central China Contract Pharmaceutical Manufacturing Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Contract Pharmaceutical Manufacturing (2012-2022)
        1.5.1 China Contract Pharmaceutical Manufacturing Sales (K Pcs) and Growth Rate (%)(2012-2022)
        1.5.2 China Contract Pharmaceutical Manufacturing Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Contract Pharmaceutical Manufacturing Market Competition by Players/Manufacturers
    2.1 China Contract Pharmaceutical Manufacturing Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Contract Pharmaceutical Manufacturing Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Contract Pharmaceutical Manufacturing Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
    2.4 China Contract Pharmaceutical Manufacturing Market Competitive Situation and Trends
        2.4.1 China Contract Pharmaceutical Manufacturing Market Concentration Rate
        2.4.2 China Contract Pharmaceutical Manufacturing Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Contract Pharmaceutical Manufacturing Manufacturing Base Distribution, Sales Area, Product Types

3 China Contract Pharmaceutical Manufacturing Sales and Revenue by Region (2012-2017)
    3.1 China Contract Pharmaceutical Manufacturing Sales (K Pcs) and Market Share by Region (2012-2017)
    3.2 China Contract Pharmaceutical Manufacturing Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Contract Pharmaceutical Manufacturing Price (USD/Pcs) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Contract Pharmaceutical Manufacturing Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Contract Pharmaceutical Manufacturing Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Contract Pharmaceutical Manufacturing Price (USD/Pcs) by Type (2012-2017)
    4.4 China Contract Pharmaceutical Manufacturing Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Contract Pharmaceutical Manufacturing Sales (K Pcs) and Market Share by Application (2012-2017)
    5.2 China Contract Pharmaceutical Manufacturing Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Contract Pharmaceutical Manufacturing Players/Suppliers Profiles and Sales Data
    6.1 Catalent
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Contract Pharmaceutical Manufacturing Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Catalent Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 DPx
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Contract Pharmaceutical Manufacturing Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 DPx Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Lonza
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Contract Pharmaceutical Manufacturing Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Lonza Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Piramal Healthcare
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Contract Pharmaceutical Manufacturing Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Aenova
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Contract Pharmaceutical Manufacturing Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Aenova Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Jubilant
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Contract Pharmaceutical Manufacturing Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Jubilant Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Famar
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Contract Pharmaceutical Manufacturing Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Famar Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Boehringer Ingelheim
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Contract Pharmaceutical Manufacturing Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Fareva Holding
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Contract Pharmaceutical Manufacturing Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 AbbVie
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Contract Pharmaceutical Manufacturing Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 AbbVie Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Nipro Corp
    6.12 Vetter
    6.13 Sopharma
    6.14 DPT Laboratories
    6.15 Recipharm
    6.16 NextPharma
    6.17 Dishman
    6.18 Aesica

7 Contract Pharmaceutical Manufacturing Manufacturing Cost Analysis
    7.1 Contract Pharmaceutical Manufacturing Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Contract Pharmaceutical Manufacturing

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Contract Pharmaceutical Manufacturing Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Contract Pharmaceutical Manufacturing Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Contract Pharmaceutical Manufacturing Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Contract Pharmaceutical Manufacturing Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Contract Pharmaceutical Manufacturing Sales (K Pcs) Forecast by Type (2017-2022)
    11.3 China Contract Pharmaceutical Manufacturing Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 China Contract Pharmaceutical Manufacturing Sales (K Pcs) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List